The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Mathias Rummel, N. Niederle, Georg Maschmeyer et al. · The Lancet · 2013 · 1.5K citations

Medicine, Oncology, Pharmacology +6

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Eva Hoster, Martin Dreyling, Christian Gisselbrecht et al. · Blood · 2007 · 971 citations

Medicine, Hematology, Oncology +11

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

Verónica Fernández, Olga Salamero, Blanca Espinet et al. · Cancer Research · 2010 · 461 citations

Medicine, Hematology, Oncology +17

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

Kirit M. Ardeshna, Wendi Qian, Paul Smith et al. · The Lancet Oncology · 2014 · 388 citations

Medicine, Oncology, Pharmacotherapy +8

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

Eva Hoster, Andreas Rosenwald, Françoise Berger et al. · Journal of Clinical Oncology · 2016 · 362 citations

Medicine, Oncology, Pathology +17